Back

Risk of cardiovascular disease in Hodgkin lymphoma patients

31 August 2024 (09:50 - 10:00)
Organised by: Logo
Congress Presentation Part of: Daily cardiac problems in cancer patients Cardio-Oncology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Sissel Johanne Godtfredsen

Aalborg University Hospital, Aalborg (Denmark)

5 More presentations in this session

Presentation thumbnail
The initial high-dose versus maintenance-dose anticoagulation therapy with direct oral anticoagulants for cancer-associated venous thromboembolism: from the COMMAND VTE Registry-2
Doctor R. Chatani (Kurashiki, JP)
Abstract Slides Video
Presentation thumbnail
Understanding the impact of heart failure treatment on cancer growth
Miss C. Civati (Antwerp, BE)
Abstract Slides Video
Presentation thumbnail
Prediction of cancer therapy related cardiac dysfunction by using a machine learning approach with cardiac magnetic resonance images
Doctor C. Yu (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Increased prevalence of coronary atherosclerosis in cancer survivors: a matched cross-sectional study with coronary CT angiography
Miss E. Polomski (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitors in patients with amyloidosis and heart failure: a worldwide retrospective cohort study
Doctor R. Belo Nunes (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Daily cardiac problems in cancer patients
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 09:50 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular disease burden and risk factor management in cancer survivors: insights from a large-scale East London cohort
thumbnail
Congress Session
Risk prediction and treatment options in cardio-oncology
thumbnail
Congress Presentation
Unveiling the heartbeat of hope: exploring cardiovascular morbidity, mortality, and socioeconomic threads in 65,173 Child, Adolescent, and Young Adult (caya) cancer patients.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources